

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87912336 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.86932576 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.86932576 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.65800272 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61567968 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.60213408 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.37664482 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.34088438 |
| 9 | response to pheromone (GO:0019236) | 4.32136629 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.85762349 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85073121 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85073121 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.85073121 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85073121 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.85073121 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85073121 |
| 17 | neutrophil activation (GO:0042119) | 3.65801187 |
| 18 | activated T cell proliferation (GO:0050798) | 3.62921649 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.57496388 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43440163 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.42076523 |
| 22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.41087911 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.40483577 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40053612 |
| 25 | chaperone-mediated protein transport (GO:0072321) | 3.39583925 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37289132 |
| 27 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.36397703 |
| 28 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36123133 |
| 29 | granulocyte activation (GO:0036230) | 3.35096400 |
| 30 | detection of other organism (GO:0098543) | 3.32122118 |
| 31 | protein localization to synapse (GO:0035418) | 3.31767104 |
| 32 | detection of bacterium (GO:0016045) | 3.30151927 |
| 33 | neuron cell-cell adhesion (GO:0007158) | 3.29777954 |
| 34 | glutamate secretion (GO:0014047) | 3.28564223 |
| 35 | negative regulation of innate immune response (GO:0045824) | 3.26655365 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26103622 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.25937334 |
| 38 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.25157726 |
| 39 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.24408735 |
| 40 | regulation of regulatory T cell differentiation (GO:0045589) | 3.22046717 |
| 41 | leukocyte aggregation (GO:0070486) | 3.21720225 |
| 42 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.20736392 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.18352090 |
| 44 | synaptic vesicle maturation (GO:0016188) | 3.17489126 |
| 45 | response to peptidoglycan (GO:0032494) | 3.17415196 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 3.17157280 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.13682995 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12397887 |
| 49 | neuronal action potential propagation (GO:0019227) | 3.11656922 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.07595134 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.07490034 |
| 52 | response to type I interferon (GO:0034340) | 3.06610781 |
| 53 | negative regulation of interleukin-6 production (GO:0032715) | 3.04311976 |
| 54 | response to interferon-beta (GO:0035456) | 3.04006859 |
| 55 | regulation of T cell tolerance induction (GO:0002664) | 3.03872268 |
| 56 | positive regulation of defense response to virus by host (GO:0002230) | 3.03493609 |
| 57 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.02140316 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.01123423 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.01123423 |
| 60 | postsynaptic membrane organization (GO:0001941) | 3.01049898 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00800969 |
| 62 | neutrophil mediated immunity (GO:0002446) | 2.98755585 |
| 63 | regulation of mast cell degranulation (GO:0043304) | 2.97988798 |
| 64 | DNA deamination (GO:0045006) | 2.96776119 |
| 65 | regulation of mast cell activation (GO:0033003) | 2.96579960 |
| 66 | pH reduction (GO:0045851) | 2.93076301 |
| 67 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.92819915 |
| 68 | vocalization behavior (GO:0071625) | 2.91201057 |
| 69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90697520 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90096224 |
| 71 | response to host immune response (GO:0052572) | 2.90096224 |
| 72 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.89268986 |
| 73 | tolerance induction (GO:0002507) | 2.88183426 |
| 74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87898489 |
| 75 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.86788730 |
| 76 | response to host (GO:0075136) | 2.86636910 |
| 77 | response to host defenses (GO:0052200) | 2.86636910 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86636910 |
| 79 | signal peptide processing (GO:0006465) | 2.86251659 |
| 80 | mannose metabolic process (GO:0006013) | 2.86083331 |
| 81 | interferon-gamma secretion (GO:0072643) | 2.84907437 |
| 82 | intracellular pH reduction (GO:0051452) | 2.84766223 |
| 83 | cellular extravasation (GO:0045123) | 2.82603028 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.81431109 |
| 85 | neuromuscular process controlling posture (GO:0050884) | 2.80380811 |
| 86 | positive thymic T cell selection (GO:0045059) | 2.79510091 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.79481413 |
| 88 | neurotransmitter secretion (GO:0007269) | 2.78632574 |
| 89 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.78476542 |
| 90 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.77690177 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77408277 |
| 92 | response to interleukin-15 (GO:0070672) | 2.76441265 |
| 93 | cytidine metabolic process (GO:0046087) | 2.75094932 |
| 94 | cytidine catabolic process (GO:0006216) | 2.75094932 |
| 95 | cytidine deamination (GO:0009972) | 2.75094932 |
| 96 | negative regulation of interleukin-1 production (GO:0032692) | 2.73506019 |
| 97 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.73064457 |
| 98 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.73064457 |
| 99 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.73052387 |
| 100 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.73052387 |
| 101 | positive regulation of mast cell activation (GO:0033005) | 2.72923174 |
| 102 | detection of external biotic stimulus (GO:0098581) | 2.72802411 |
| 103 | respiratory burst (GO:0045730) | 2.72531783 |
| 104 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.72416407 |
| 105 | transferrin transport (GO:0033572) | 2.72360364 |
| 106 | C4-dicarboxylate transport (GO:0015740) | 2.72357138 |
| 107 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.70870462 |
| 108 | cellular response to interleukin-15 (GO:0071350) | 2.70569511 |
| 109 | phagosome maturation (GO:0090382) | 2.69940710 |
| 110 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69668057 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67823023 |
| 112 | microglial cell activation (GO:0001774) | 2.67604058 |
| 113 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.67105264 |
| 114 | leukocyte degranulation (GO:0043299) | 2.65442673 |
| 115 | regulation of T cell cytokine production (GO:0002724) | 2.64921950 |
| 116 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64339911 |
| 117 | Golgi transport vesicle coating (GO:0048200) | 2.62776152 |
| 118 | COPI coating of Golgi vesicle (GO:0048205) | 2.62776152 |
| 119 | locomotory exploration behavior (GO:0035641) | 2.62482941 |
| 120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62441194 |
| 121 | response to auditory stimulus (GO:0010996) | 2.61384353 |
| 122 | positive T cell selection (GO:0043368) | 2.60777897 |
| 123 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.60230404 |
| 124 | negative thymic T cell selection (GO:0045060) | 2.60053237 |
| 125 | acidic amino acid transport (GO:0015800) | 2.59748194 |
| 126 | cellular response to exogenous dsRNA (GO:0071360) | 2.59054210 |
| 127 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.57087414 |
| 128 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.57015166 |
| 129 | interferon-gamma production (GO:0032609) | 2.56767320 |
| 130 | negative T cell selection (GO:0043383) | 2.56714498 |
| 131 | macrophage activation (GO:0042116) | 2.56372923 |
| 132 | response to misfolded protein (GO:0051788) | 2.54001457 |
| 133 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.53992728 |
| 134 | regulation of cell killing (GO:0031341) | 2.53914453 |
| 135 | mast cell activation (GO:0045576) | 2.52349009 |
| 136 | positive regulation of granulocyte differentiation (GO:0030854) | 2.52259747 |
| 137 | response to muramyl dipeptide (GO:0032495) | 2.52184582 |
| 138 | regulation of synapse structural plasticity (GO:0051823) | 2.51943935 |
| 139 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.51373719 |
| 140 | L-glutamate transport (GO:0015813) | 2.50888730 |
| 141 | trivalent inorganic cation transport (GO:0072512) | 2.46258934 |
| 142 | ferric iron transport (GO:0015682) | 2.46258934 |
| 143 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.43891991 |
| 144 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.43678730 |
| 145 | exploration behavior (GO:0035640) | 2.42129191 |
| 146 | peroxisome fission (GO:0016559) | 2.41889185 |
| 147 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.37206574 |
| 148 | nucleobase catabolic process (GO:0046113) | 2.36792982 |
| 149 | endosome to melanosome transport (GO:0035646) | 2.33698783 |
| 150 | endosome to pigment granule transport (GO:0043485) | 2.33698783 |
| 151 | synaptic transmission, glutamatergic (GO:0035249) | 2.33268837 |
| 152 | auditory behavior (GO:0031223) | 2.32004140 |
| 153 | regulation of neuron projection regeneration (GO:0070570) | 2.31802507 |
| 154 | regulation of axon regeneration (GO:0048679) | 2.31802507 |
| 155 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.29639908 |
| 156 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.28030208 |
| 157 | establishment of synaptic vesicle localization (GO:0097480) | 2.27683909 |
| 158 | synaptic vesicle transport (GO:0048489) | 2.27683909 |
| 159 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.26764089 |
| 160 | mechanosensory behavior (GO:0007638) | 2.26673397 |
| 161 | oligosaccharide biosynthetic process (GO:0009312) | 2.25373299 |
| 162 | long-term synaptic potentiation (GO:0060291) | 2.25192488 |
| 163 | neuron-neuron synaptic transmission (GO:0007270) | 2.24255447 |
| 164 | serine transport (GO:0032329) | 2.23261958 |
| 165 | NADH metabolic process (GO:0006734) | 2.22791480 |
| 166 | regulation of vesicle fusion (GO:0031338) | 2.22022400 |
| 167 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.21853326 |
| 168 | anterograde axon cargo transport (GO:0008089) | 2.21687581 |
| 169 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.20316073 |
| 170 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.20316073 |
| 171 | mannosylation (GO:0097502) | 2.18582625 |
| 172 | neurotransmitter transport (GO:0006836) | 2.17608844 |
| 173 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.17371819 |
| 174 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.16800488 |
| 175 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.15181340 |
| 176 | gamma-aminobutyric acid transport (GO:0015812) | 2.14646590 |
| 177 | regulation of neurotransmitter levels (GO:0001505) | 2.13681618 |
| 178 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.13042556 |
| 179 | regulation of neurotransmitter secretion (GO:0046928) | 2.12957015 |
| 180 | anterograde synaptic vesicle transport (GO:0048490) | 2.11494597 |
| 181 | mitochondrion degradation (GO:0000422) | 2.11340143 |
| 182 | positive regulation of membrane potential (GO:0045838) | 2.10543973 |
| 183 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.09517304 |
| 184 | glutathione biosynthetic process (GO:0006750) | 2.09420245 |
| 185 | ganglioside metabolic process (GO:0001573) | 2.08899130 |
| 186 | fucosylation (GO:0036065) | 2.07518635 |
| 187 | synaptic vesicle endocytosis (GO:0048488) | 2.06492562 |
| 188 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.06456989 |
| 189 | cell communication by electrical coupling (GO:0010644) | 2.06340769 |
| 190 | negative regulation of dendrite development (GO:2000171) | 2.05552740 |
| 191 | regulation of autophagic vacuole assembly (GO:2000785) | 2.05479246 |
| 192 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.04246840 |
| 193 | sterol catabolic process (GO:0016127) | 2.04124369 |
| 194 | cholesterol catabolic process (GO:0006707) | 2.04124369 |
| 195 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.03773479 |
| 196 | negative regulation of B cell mediated immunity (GO:0002713) | 2.03773479 |
| 197 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.03768947 |
| 198 | Rac protein signal transduction (GO:0016601) | 2.03726159 |
| 199 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.03254022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34015129 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.74676963 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58206906 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.54740575 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.51240634 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.49201800 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.33119764 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.30024416 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29768457 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.25517922 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23002336 |
| 12 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16088476 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15665677 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14668422 |
| 15 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.09931662 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07927002 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.06042147 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06002152 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04731433 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04245624 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03394788 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01110682 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.98254748 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96267158 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95963626 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95417047 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94515894 |
| 28 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.89409523 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88082847 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88082847 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.86365957 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.84178242 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.83285837 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81879558 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80321176 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80239970 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.79829956 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78436691 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76615652 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.74373908 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70618123 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70549192 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65650386 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61269068 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60535399 |
| 46 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.59043440 |
| 47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57469244 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57242764 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.56578634 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.54950803 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53784396 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52592522 |
| 53 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.49652403 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48386448 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44709379 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43124653 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43102109 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42384729 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42225483 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38073973 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37207375 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37195322 |
| 63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36957373 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36616758 |
| 65 | P300_27268052_Chip-Seq_Bcells_Human | 1.34412944 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34207616 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34034400 |
| 68 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33933845 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32745566 |
| 70 | ERA_21632823_ChIP-Seq_H3396_Human | 1.31283522 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31080115 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30023272 |
| 73 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.29266998 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28776077 |
| 75 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28392160 |
| 76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27816519 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25195553 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24293342 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23863355 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22964311 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22537742 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21250277 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20605274 |
| 84 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.20112288 |
| 85 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20035428 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19459114 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19136822 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18858524 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18414954 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18410165 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.17942928 |
| 92 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17844414 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17497594 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15706333 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14955869 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13763233 |
| 97 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.11807560 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11614911 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11300630 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10633018 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10617173 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10537192 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08959945 |
| 104 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.08881188 |
| 105 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08655721 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08407287 |
| 107 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08002067 |
| 108 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07035117 |
| 109 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05922400 |
| 110 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05603138 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05516818 |
| 112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05280743 |
| 113 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05248033 |
| 114 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04590412 |
| 115 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03478539 |
| 116 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03238477 |
| 117 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02952609 |
| 118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01218739 |
| 119 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01133935 |
| 120 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00433429 |
| 121 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97909435 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96445983 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95349639 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95064985 |
| 125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94826647 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92967865 |
| 127 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91067539 |
| 128 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90134805 |
| 129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89054020 |
| 130 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87842704 |
| 131 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86386706 |
| 132 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86071626 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85092391 |
| 134 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84403179 |
| 135 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84012831 |
| 136 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.83877509 |
| 137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83080274 |
| 138 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82932023 |
| 139 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.82114651 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81388760 |
| 141 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.81076735 |
| 142 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78908490 |
| 143 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78760637 |
| 144 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.78162612 |
| 145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78147153 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76209958 |
| 147 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.76092859 |
| 148 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75992529 |
| 149 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.75780183 |
| 150 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75035114 |
| 151 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.74750075 |
| 152 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74722462 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.74558050 |
| 154 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.73990366 |
| 155 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.73779399 |
| 156 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.73755779 |
| 157 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.73231938 |
| 158 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.72870460 |
| 159 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72258483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.10480510 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.94122880 |
| 3 | MP0003880_abnormal_central_pattern | 3.23746291 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.21900953 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.69297983 |
| 6 | MP0000685_abnormal_immune_system | 2.66561627 |
| 7 | MP0002736_abnormal_nociception_after | 2.62193643 |
| 8 | MP0005387_immune_system_phenotype | 2.60704040 |
| 9 | MP0001790_abnormal_immune_system | 2.60704040 |
| 10 | MP0001800_abnormal_humoral_immune | 2.60105645 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.55446164 |
| 12 | MP0002723_abnormal_immune_serum | 2.52721865 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.52053422 |
| 14 | MP0004270_analgesia | 2.48681620 |
| 15 | MP0003303_peritoneal_inflammation | 2.40030310 |
| 16 | MP0002064_seizures | 2.37369008 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.32979304 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.31040295 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.28686170 |
| 20 | MP0001819_abnormal_immune_cell | 2.26416351 |
| 21 | MP0003329_amyloid_beta_deposits | 2.26374375 |
| 22 | MP0002063_abnormal_learning/memory/cond | 2.24948121 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.19924757 |
| 24 | MP0009745_abnormal_behavioral_response | 2.12076007 |
| 25 | MP0004858_abnormal_nervous_system | 2.12015121 |
| 26 | MP0005646_abnormal_pituitary_gland | 2.10212703 |
| 27 | MP0006276_abnormal_autonomic_nervous | 2.03547020 |
| 28 | MP0009764_decreased_sensitivity_to | 2.01551663 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.99385378 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.98298276 |
| 31 | MP0009840_abnormal_foam_cell | 1.96917817 |
| 32 | MP0002272_abnormal_nervous_system | 1.96153453 |
| 33 | MP0009046_muscle_twitch | 1.95605025 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.88675739 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.81614582 |
| 36 | MP0001970_abnormal_pain_threshold | 1.77075693 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.76180233 |
| 38 | MP0009278_abnormal_bone_marrow | 1.73298815 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.71110604 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.70318802 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.69094778 |
| 42 | MP0000716_abnormal_immune_system | 1.65375492 |
| 43 | MP0001905_abnormal_dopamine_level | 1.63939703 |
| 44 | MP0002405_respiratory_system_inflammati | 1.63110002 |
| 45 | MP0003879_abnormal_hair_cell | 1.63103216 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.61567210 |
| 47 | MP0001873_stomach_inflammation | 1.57357129 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.56056963 |
| 49 | MP0008469_abnormal_protein_level | 1.53210719 |
| 50 | MP0004142_abnormal_muscle_tone | 1.52425543 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.52393663 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.51286969 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.48265873 |
| 54 | MP0008260_abnormal_autophagy | 1.46351223 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.45932396 |
| 56 | MP0001984_abnormal_olfaction | 1.45522419 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.45072684 |
| 58 | MP0000604_amyloidosis | 1.44966062 |
| 59 | MP0002398_abnormal_bone_marrow | 1.44377452 |
| 60 | MP0001501_abnormal_sleep_pattern | 1.43547615 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.43215514 |
| 62 | MP0003075_altered_response_to | 1.43001906 |
| 63 | MP0002184_abnormal_innervation | 1.41312374 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.41114881 |
| 65 | MP0001529_abnormal_vocalization | 1.39664956 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.37524931 |
| 67 | MP0004147_increased_porphyrin_level | 1.36953320 |
| 68 | MP0008569_lethality_at_weaning | 1.35800265 |
| 69 | MP0002067_abnormal_sensory_capabilities | 1.34443232 |
| 70 | MP0001486_abnormal_startle_reflex | 1.33501363 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.27920230 |
| 72 | MP0001545_abnormal_hematopoietic_system | 1.27920230 |
| 73 | MP0002557_abnormal_social/conspecific_i | 1.26059028 |
| 74 | MP0002429_abnormal_blood_cell | 1.24700920 |
| 75 | MP0001664_abnormal_digestion | 1.24653467 |
| 76 | MP0003787_abnormal_imprinting | 1.21581351 |
| 77 | MP0004811_abnormal_neuron_physiology | 1.21324416 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.19146688 |
| 79 | MP0009785_altered_susceptibility_to | 1.18250828 |
| 80 | MP0002722_abnormal_immune_system | 1.18237948 |
| 81 | MP0002132_abnormal_respiratory_system | 1.17394327 |
| 82 | MP0000920_abnormal_myelination | 1.16276032 |
| 83 | MP0000955_abnormal_spinal_cord | 1.14097576 |
| 84 | MP0003690_abnormal_glial_cell | 1.13172510 |
| 85 | MP0004947_skin_inflammation | 1.12918337 |
| 86 | MP0005410_abnormal_fertilization | 1.11548377 |
| 87 | MP0000858_altered_metastatic_potential | 1.10123971 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 1.09565518 |
| 89 | MP0005423_abnormal_somatic_nervous | 1.09528982 |
| 90 | MP0005671_abnormal_response_to | 1.09341664 |
| 91 | MP0002090_abnormal_vision | 1.09132153 |
| 92 | MP0001835_abnormal_antigen_presentation | 1.07430364 |
| 93 | MP0002102_abnormal_ear_morphology | 1.07411293 |
| 94 | MP0003633_abnormal_nervous_system | 1.06671206 |
| 95 | MP0000681_abnormal_thyroid_gland | 1.05084510 |
| 96 | MP0003300_gastrointestinal_ulcer | 1.04949591 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 1.04808124 |
| 98 | MP0003011_delayed_dark_adaptation | 1.04482087 |
| 99 | MP0002822_catalepsy | 1.04330965 |
| 100 | MP0005390_skeleton_phenotype | 1.00932542 |
| 101 | MP0002653_abnormal_ependyma_morphology | 0.99121047 |
| 102 | MP0003828_pulmonary_edema | 0.99115571 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98129332 |
| 104 | MP0002066_abnormal_motor_capabilities/c | 0.96954449 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.96751662 |
| 106 | MP0003195_calcinosis | 0.96549952 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.95367472 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.94387953 |
| 109 | MP0001188_hyperpigmentation | 0.93731374 |
| 110 | MP0002229_neurodegeneration | 0.92761824 |
| 111 | MP0002882_abnormal_neuron_morphology | 0.92626271 |
| 112 | MP0004924_abnormal_behavior | 0.91991499 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.91991499 |
| 114 | MP0003631_nervous_system_phenotype | 0.91478780 |
| 115 | MP0000778_abnormal_nervous_system | 0.91311489 |
| 116 | MP0005365_abnormal_bile_salt | 0.91148324 |
| 117 | MP0008872_abnormal_physiological_respon | 0.90906715 |
| 118 | MP0006082_CNS_inflammation | 0.90179315 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.89556370 |
| 120 | MP0001663_abnormal_digestive_system | 0.88659272 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.87801786 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.86668549 |
| 123 | MP0003634_abnormal_glial_cell | 0.85986030 |
| 124 | MP0001853_heart_inflammation | 0.85704040 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.84214879 |
| 126 | MP0002069_abnormal_eating/drinking_beha | 0.84155435 |
| 127 | MP0005535_abnormal_body_temperature | 0.83641064 |
| 128 | MP0004883_abnormal_blood_vessel | 0.83527421 |
| 129 | MP0001764_abnormal_homeostasis | 0.83272218 |
| 130 | MP0002933_joint_inflammation | 0.83041007 |
| 131 | MP0002254_reproductive_system_inflammat | 0.82057302 |
| 132 | MP0005310_abnormal_salivary_gland | 0.81533121 |
| 133 | MP0000343_altered_response_to | 0.81484443 |
| 134 | MP0002148_abnormal_hypersensitivity_rea | 0.80968617 |
| 135 | MP0009763_increased_sensitivity_to | 0.80559620 |
| 136 | MP0002928_abnormal_bile_duct | 0.78241529 |
| 137 | MP0001542_abnormal_bone_strength | 0.77909308 |
| 138 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77795678 |
| 139 | MP0003436_decreased_susceptibility_to | 0.77539430 |
| 140 | MP0005164_abnormal_response_to | 0.77293172 |
| 141 | MP0005083_abnormal_biliary_tract | 0.77207197 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.76982932 |
| 143 | MP0005166_decreased_susceptibility_to | 0.76187126 |
| 144 | MP0002638_abnormal_pupillary_reflex | 0.76018406 |
| 145 | MP0000538_abnormal_urinary_bladder | 0.75672110 |
| 146 | MP0005000_abnormal_immune_tolerance | 0.75350364 |
| 147 | MP0002419_abnormal_innate_immunity | 0.75246361 |
| 148 | MP0005174_abnormal_tail_pigmentation | 0.75189260 |
| 149 | MP0000015_abnormal_ear_pigmentation | 0.74611409 |
| 150 | MP0000465_gastrointestinal_hemorrhage | 0.74603101 |
| 151 | MP0000013_abnormal_adipose_tissue | 0.74571656 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.73852820 |
| 153 | MP0004510_myositis | 0.73839813 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.73120498 |
| 155 | MP0002089_abnormal_postnatal_growth/wei | 0.72307521 |
| 156 | MP0008874_decreased_physiological_sensi | 0.72158922 |
| 157 | MP0000249_abnormal_blood_vessel | 0.70894615 |
| 158 | MP0005025_abnormal_response_to | 0.70324241 |
| 159 | MP0003866_abnormal_defecation | 0.69414493 |
| 160 | MP0004130_abnormal_muscle_cell | 0.69285720 |
| 161 | MP0001348_abnormal_lacrimal_gland | 0.68431737 |
| 162 | MP0004043_abnormal_pH_regulation | 0.67692845 |
| 163 | MP0004381_abnormal_hair_follicle | 0.66682350 |
| 164 | MP0001851_eye_inflammation | 0.66029388 |
| 165 | MP0002138_abnormal_hepatobiliary_system | 0.65289572 |
| 166 | MP0003795_abnormal_bone_structure | 0.64998360 |
| 167 | MP0002693_abnormal_pancreas_physiology | 0.63542495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.01945096 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.77421944 |
| 3 | Stomatitis (HP:0010280) | 4.55256587 |
| 4 | Orchitis (HP:0100796) | 4.51816550 |
| 5 | Optic neuritis (HP:0100653) | 4.20557825 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.20557825 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12950560 |
| 8 | Myokymia (HP:0002411) | 3.96205904 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.92437460 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.84409162 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.74082038 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.66706275 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.66706275 |
| 14 | Focal motor seizures (HP:0011153) | 3.63294614 |
| 15 | Hypochromic anemia (HP:0001931) | 3.57910111 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.53976850 |
| 17 | Polyphagia (HP:0002591) | 3.47340025 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.46254768 |
| 19 | Encephalitis (HP:0002383) | 3.46081196 |
| 20 | Hypothermia (HP:0002045) | 3.42518792 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.42368003 |
| 22 | Pustule (HP:0200039) | 3.41241333 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.34208113 |
| 24 | Pheochromocytoma (HP:0002666) | 3.32535875 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.31891399 |
| 26 | Epileptic encephalopathy (HP:0200134) | 3.29113877 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.21820479 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 3.20410876 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 3.06303807 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00865886 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00865886 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00865886 |
| 33 | Atonic seizures (HP:0010819) | 2.99433876 |
| 34 | Poor suck (HP:0002033) | 2.95558820 |
| 35 | Failure to thrive in infancy (HP:0001531) | 2.95435545 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.95238175 |
| 37 | Cholecystitis (HP:0001082) | 2.95238175 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.90543866 |
| 39 | Recurrent skin infections (HP:0001581) | 2.86582632 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.84986270 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.75737742 |
| 42 | Increased IgE level (HP:0003212) | 2.75648227 |
| 43 | Obstructive lung disease (HP:0006536) | 2.75602654 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75602654 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.74285999 |
| 46 | Meningitis (HP:0001287) | 2.74191316 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.73464802 |
| 48 | Vasculitis (HP:0002633) | 2.70449770 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65077198 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.62734139 |
| 51 | Increased IgM level (HP:0003496) | 2.60758364 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.59435228 |
| 53 | Hemoptysis (HP:0002105) | 2.58913652 |
| 54 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.57369851 |
| 55 | Hyperventilation (HP:0002883) | 2.54575198 |
| 56 | Febrile seizures (HP:0002373) | 2.54130779 |
| 57 | Leukocytosis (HP:0001974) | 2.52793270 |
| 58 | Increased serum ferritin (HP:0003281) | 2.51488858 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.50919282 |
| 60 | Progressive microcephaly (HP:0000253) | 2.50699797 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.50153538 |
| 62 | Cortical visual impairment (HP:0100704) | 2.49932396 |
| 63 | Focal seizures (HP:0007359) | 2.49154697 |
| 64 | Loss of speech (HP:0002371) | 2.48230356 |
| 65 | Ankle clonus (HP:0011448) | 2.46596103 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.44301130 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.43492091 |
| 68 | Episodic fever (HP:0001954) | 2.43246392 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.42449305 |
| 70 | Abnormal hair whorl (HP:0010721) | 2.40992718 |
| 71 | Attenuation of retinal blood vessels (HP:0007843) | 2.39468779 |
| 72 | Granulocytopenia (HP:0001913) | 2.38662336 |
| 73 | Visual hallucinations (HP:0002367) | 2.38202419 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.35646914 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.33275470 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.33275470 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33275470 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33275470 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.31008471 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 2.29437411 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28970575 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28970575 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28970575 |
| 84 | Focal dystonia (HP:0004373) | 2.28236869 |
| 85 | Chronic otitis media (HP:0000389) | 2.27424691 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.25490594 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.24822950 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24822950 |
| 89 | Esotropia (HP:0000565) | 2.24442480 |
| 90 | Craniofacial dystonia (HP:0012179) | 2.24149681 |
| 91 | Eosinophilia (HP:0001880) | 2.23155355 |
| 92 | Hepatocellular necrosis (HP:0001404) | 2.22736509 |
| 93 | Prolonged bleeding time (HP:0003010) | 2.22711888 |
| 94 | Urticaria (HP:0001025) | 2.22384037 |
| 95 | Abnormality of T cells (HP:0002843) | 2.21697807 |
| 96 | IgG deficiency (HP:0004315) | 2.21116142 |
| 97 | Spastic gait (HP:0002064) | 2.20525951 |
| 98 | Agitation (HP:0000713) | 2.19740711 |
| 99 | Large eyes (HP:0001090) | 2.18605573 |
| 100 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.18319184 |
| 101 | Delusions (HP:0000746) | 2.16256294 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.15830810 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.15486400 |
| 104 | Chest pain (HP:0100749) | 2.15004458 |
| 105 | Anxiety (HP:0000739) | 2.13147625 |
| 106 | Scanning speech (HP:0002168) | 2.12698904 |
| 107 | Microcytic anemia (HP:0001935) | 2.12367699 |
| 108 | Absence seizures (HP:0002121) | 2.12059417 |
| 109 | Abnormality of the pleura (HP:0002103) | 2.11753666 |
| 110 | Torticollis (HP:0000473) | 2.11189975 |
| 111 | Agammaglobulinemia (HP:0004432) | 2.09742162 |
| 112 | Stomach cancer (HP:0012126) | 2.08581749 |
| 113 | Amyloidosis (HP:0011034) | 2.06975832 |
| 114 | Depression (HP:0000716) | 2.06248589 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 2.05141737 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.03819449 |
| 117 | Abnormality of T cell number (HP:0011839) | 2.03646958 |
| 118 | Asymmetric septal hypertrophy (HP:0001670) | 2.03075493 |
| 119 | Akinesia (HP:0002304) | 2.02889714 |
| 120 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02711067 |
| 121 | Poor speech (HP:0002465) | 2.01576051 |
| 122 | Mitochondrial inheritance (HP:0001427) | 2.01196706 |
| 123 | Hepatic necrosis (HP:0002605) | 1.98981482 |
| 124 | Generalized aminoaciduria (HP:0002909) | 1.97891070 |
| 125 | Hepatosplenomegaly (HP:0001433) | 1.97731274 |
| 126 | Progressive inability to walk (HP:0002505) | 1.97409869 |
| 127 | Anorexia (HP:0002039) | 1.97302777 |
| 128 | Type I transferrin isoform profile (HP:0003642) | 1.96629660 |
| 129 | Peritonitis (HP:0002586) | 1.95340305 |
| 130 | Renal Fanconi syndrome (HP:0001994) | 1.95048458 |
| 131 | Keratitis (HP:0000491) | 1.94555890 |
| 132 | Opisthotonus (HP:0002179) | 1.94127425 |
| 133 | Growth hormone excess (HP:0000845) | 1.93608364 |
| 134 | Progressive cerebellar ataxia (HP:0002073) | 1.92057615 |
| 135 | Acute necrotizing encephalopathy (HP:0006965) | 1.92039969 |
| 136 | Severe visual impairment (HP:0001141) | 1.91682269 |
| 137 | Spastic paraparesis (HP:0002313) | 1.91156490 |
| 138 | Recurrent viral infections (HP:0004429) | 1.90243258 |
| 139 | Dialeptic seizures (HP:0011146) | 1.89440429 |
| 140 | Inability to walk (HP:0002540) | 1.89262519 |
| 141 | Oligomenorrhea (HP:0000876) | 1.89188998 |
| 142 | Abnormality of midbrain morphology (HP:0002418) | 1.88164422 |
| 143 | Molar tooth sign on MRI (HP:0002419) | 1.88164422 |
| 144 | Muscular hypotonia of the trunk (HP:0008936) | 1.88021035 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.87946179 |
| 146 | Hyperbilirubinemia (HP:0002904) | 1.86806134 |
| 147 | Petechiae (HP:0000967) | 1.86473902 |
| 148 | Colitis (HP:0002583) | 1.86067223 |
| 149 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.85767771 |
| 150 | Hypoplasia of the brainstem (HP:0002365) | 1.85767771 |
| 151 | Truncal ataxia (HP:0002078) | 1.85363040 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.84690000 |
| 153 | Diplopia (HP:0000651) | 1.84690000 |
| 154 | Generalized tonic-clonic seizures (HP:0002069) | 1.84472702 |
| 155 | Autoimmune thrombocytopenia (HP:0001973) | 1.84011823 |
| 156 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83589254 |
| 157 | Psychosis (HP:0000709) | 1.83509740 |
| 158 | Decreased central vision (HP:0007663) | 1.83255659 |
| 159 | Cheilitis (HP:0100825) | 1.82031260 |
| 160 | Paraparesis (HP:0002385) | 1.81616441 |
| 161 | Gingivitis (HP:0000230) | 1.81285520 |
| 162 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.80929529 |
| 163 | Lissencephaly (HP:0001339) | 1.80559133 |
| 164 | Systemic lupus erythematosus (HP:0002725) | 1.79884131 |
| 165 | Pulmonary embolism (HP:0002204) | 1.79536029 |
| 166 | Acne (HP:0001061) | 1.78732916 |
| 167 | Hematochezia (HP:0002573) | 1.78267500 |
| 168 | Spinal canal stenosis (HP:0003416) | 1.78197478 |
| 169 | T lymphocytopenia (HP:0005403) | 1.78187613 |
| 170 | Epistaxis (HP:0000421) | 1.77652242 |
| 171 | Prolonged neonatal jaundice (HP:0006579) | 1.77596871 |
| 172 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77086065 |
| 173 | Increased intramyocellular lipid droplets (HP:0012240) | 1.76756564 |
| 174 | Sleep apnea (HP:0010535) | 1.76643191 |
| 175 | Acute encephalopathy (HP:0006846) | 1.76444098 |
| 176 | Global brain atrophy (HP:0002283) | 1.76243441 |
| 177 | Abnormality of the pericardium (HP:0001697) | 1.76224424 |
| 178 | Cerebral hemorrhage (HP:0001342) | 1.75502978 |
| 179 | Hypoventilation (HP:0002791) | 1.74024741 |
| 180 | Brushfield spots (HP:0001088) | 1.73400620 |
| 181 | Stridor (HP:0010307) | 1.73343348 |
| 182 | Limb dystonia (HP:0002451) | 1.72211365 |
| 183 | Rigidity (HP:0002063) | 1.71928332 |
| 184 | Epileptiform EEG discharges (HP:0011182) | 1.71392229 |
| 185 | Poor eye contact (HP:0000817) | 1.70199150 |
| 186 | Mutism (HP:0002300) | 1.69754554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.03626044 |
| 2 | CDK19 | 3.00028449 |
| 3 | TNIK | 2.90606450 |
| 4 | SIK3 | 2.78719590 |
| 5 | STK16 | 2.65969642 |
| 6 | ACVR1B | 2.45161350 |
| 7 | MAP2K7 | 2.38421000 |
| 8 | CASK | 2.30407254 |
| 9 | KIT | 2.25711247 |
| 10 | TYK2 | 2.18186511 |
| 11 | TAOK3 | 2.10219257 |
| 12 | NTRK3 | 1.95287853 |
| 13 | ERN1 | 1.93640792 |
| 14 | MUSK | 1.91620079 |
| 15 | MAP3K9 | 1.87934632 |
| 16 | MINK1 | 1.87318363 |
| 17 | PRKD2 | 1.85753242 |
| 18 | JAK3 | 1.78104217 |
| 19 | ARAF | 1.71683154 |
| 20 | EPHB1 | 1.68253359 |
| 21 | MARK1 | 1.67835067 |
| 22 | CSK | 1.66839423 |
| 23 | DAPK1 | 1.62640326 |
| 24 | IKBKB | 1.53361337 |
| 25 | TESK2 | 1.52452783 |
| 26 | BLK | 1.50120077 |
| 27 | MAPK13 | 1.49553908 |
| 28 | DAPK2 | 1.42614518 |
| 29 | WNK3 | 1.39733317 |
| 30 | MYLK | 1.38215688 |
| 31 | MAP3K11 | 1.36447165 |
| 32 | EPHA4 | 1.35304018 |
| 33 | PIM2 | 1.31429032 |
| 34 | SYK | 1.30833701 |
| 35 | NTRK2 | 1.26428140 |
| 36 | MAP3K13 | 1.25327207 |
| 37 | ADRBK2 | 1.23215286 |
| 38 | MAP2K4 | 1.20820110 |
| 39 | TEC | 1.18862517 |
| 40 | NTRK1 | 1.18819134 |
| 41 | CSF1R | 1.17806022 |
| 42 | MARK3 | 1.17797610 |
| 43 | DYRK1B | 1.16742347 |
| 44 | MAP2K3 | 1.16518976 |
| 45 | TXK | 1.15515785 |
| 46 | HIPK2 | 1.15001392 |
| 47 | PRPF4B | 1.14664191 |
| 48 | HCK | 1.14315640 |
| 49 | TBK1 | 1.11958866 |
| 50 | MAPK15 | 1.11646850 |
| 51 | EPHA3 | 1.11058795 |
| 52 | LCK | 1.10988343 |
| 53 | TNK2 | 1.09525566 |
| 54 | MAP2K6 | 1.08128117 |
| 55 | CAMKK2 | 1.07650182 |
| 56 | MAP4K1 | 1.06224210 |
| 57 | INSRR | 1.05781840 |
| 58 | CCNB1 | 1.05434030 |
| 59 | IKBKE | 1.05076184 |
| 60 | ZAP70 | 1.03206609 |
| 61 | FGFR4 | 1.02873739 |
| 62 | RIPK4 | 1.02290870 |
| 63 | LIMK1 | 1.01262247 |
| 64 | MAPKAPK3 | 1.00173789 |
| 65 | CDK5 | 0.99277731 |
| 66 | BRAF | 0.96674761 |
| 67 | UHMK1 | 0.96275468 |
| 68 | FGR | 0.96145636 |
| 69 | MAP2K2 | 0.95266679 |
| 70 | BCKDK | 0.94588250 |
| 71 | FES | 0.92707447 |
| 72 | FLT3 | 0.92218705 |
| 73 | MARK2 | 0.91945996 |
| 74 | TAOK2 | 0.91500185 |
| 75 | MAP3K4 | 0.90793635 |
| 76 | OXSR1 | 0.90355933 |
| 77 | IRAK1 | 0.89664342 |
| 78 | SGK223 | 0.88880295 |
| 79 | SGK494 | 0.88880295 |
| 80 | MAPK12 | 0.88336299 |
| 81 | WNK4 | 0.87475056 |
| 82 | MATK | 0.87317932 |
| 83 | PINK1 | 0.87123801 |
| 84 | BCR | 0.86864126 |
| 85 | JAK1 | 0.84454183 |
| 86 | PHKG2 | 0.83451092 |
| 87 | PHKG1 | 0.83451092 |
| 88 | PRKCG | 0.83309179 |
| 89 | GRK5 | 0.82671477 |
| 90 | MAP3K3 | 0.82188217 |
| 91 | TLK1 | 0.80788766 |
| 92 | PRKCQ | 0.80117853 |
| 93 | PAK6 | 0.77267093 |
| 94 | NUAK1 | 0.75888105 |
| 95 | JAK2 | 0.74821998 |
| 96 | BTK | 0.72994620 |
| 97 | RPS6KA2 | 0.71582334 |
| 98 | TIE1 | 0.71033998 |
| 99 | SIK2 | 0.68830396 |
| 100 | STK38 | 0.67946771 |
| 101 | FRK | 0.66858114 |
| 102 | DYRK2 | 0.66181340 |
| 103 | GRK1 | 0.66099951 |
| 104 | ADRBK1 | 0.65895207 |
| 105 | PRKCH | 0.65760449 |
| 106 | RPS6KA6 | 0.63995962 |
| 107 | PDK1 | 0.63938707 |
| 108 | PAK3 | 0.61769905 |
| 109 | CAMKK1 | 0.60676976 |
| 110 | MAPKAPK5 | 0.60012296 |
| 111 | MAP4K2 | 0.57005935 |
| 112 | PRKCE | 0.56675260 |
| 113 | TAOK1 | 0.55196050 |
| 114 | KSR1 | 0.54450731 |
| 115 | CAMK1 | 0.54355030 |
| 116 | AKT3 | 0.53362683 |
| 117 | PRKCZ | 0.53065759 |
| 118 | PDPK1 | 0.52924627 |
| 119 | LYN | 0.51617953 |
| 120 | MAP3K14 | 0.51113598 |
| 121 | MAP3K6 | 0.50616492 |
| 122 | RPS6KL1 | 0.50164603 |
| 123 | RPS6KC1 | 0.50164603 |
| 124 | SIK1 | 0.49520495 |
| 125 | CDK18 | 0.49289562 |
| 126 | IRAK4 | 0.49008420 |
| 127 | BMPR1B | 0.48798052 |
| 128 | MAPK11 | 0.48586633 |
| 129 | GRK7 | 0.48013175 |
| 130 | PIK3CG | 0.47472709 |
| 131 | SGK2 | 0.47032141 |
| 132 | PLK2 | 0.46870458 |
| 133 | CAMK2A | 0.46395420 |
| 134 | DAPK3 | 0.45034290 |
| 135 | MAP3K7 | 0.45011331 |
| 136 | MAPK7 | 0.44582681 |
| 137 | BMX | 0.44367195 |
| 138 | CAMK2B | 0.44336949 |
| 139 | KDR | 0.43993157 |
| 140 | CDC42BPA | 0.43750958 |
| 141 | CAMK2G | 0.43460220 |
| 142 | ABL1 | 0.43122205 |
| 143 | MAP3K1 | 0.42773489 |
| 144 | PRKCD | 0.42559205 |
| 145 | RET | 0.41623115 |
| 146 | ITK | 0.41479555 |
| 147 | KSR2 | 0.41403874 |
| 148 | PRKD1 | 0.40733824 |
| 149 | STK11 | 0.40582292 |
| 150 | FYN | 0.40066665 |
| 151 | CSNK1G2 | 0.40023995 |
| 152 | CDK14 | 0.39997165 |
| 153 | RAF1 | 0.39695333 |
| 154 | GRK6 | 0.39258209 |
| 155 | MAPKAPK2 | 0.38882728 |
| 156 | PTK2B | 0.38615887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.48827070 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.96265676 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.83243023 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.60440251 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41709493 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.39005650 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.34974463 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.28896445 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27182757 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.26780532 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25189108 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97374834 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94156900 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.90982846 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.89600301 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87926809 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87011410 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.82041235 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.78596520 |
| 20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.78124806 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.75862079 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74769312 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.73929407 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.72972218 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72537931 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71911323 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67332520 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62723540 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60892027 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.60358870 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58384372 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58262730 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.56348026 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54359994 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53574280 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50422370 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.46472063 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.44471950 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43580653 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40310210 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 1.38850333 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.36904413 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32867136 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30562282 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.29656570 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.29418565 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.25387577 |
| 48 | Measles_Homo sapiens_hsa05162 | 1.24185560 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24070555 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22456602 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22126340 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21868409 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21038034 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20860615 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20629557 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.18431484 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18395322 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17629233 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17257344 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15185703 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13610480 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11203665 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08952938 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07110903 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 1.05692448 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02327594 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01518816 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 1.01421148 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 1.01319397 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00565156 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99320502 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99052510 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.97162185 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96998761 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96711597 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96568617 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96347215 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94045297 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94000056 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93796349 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93708540 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92484126 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92164215 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89809213 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87528983 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85582472 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.83968650 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83112601 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.83024371 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82578158 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81343413 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80135502 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.78785981 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.75479666 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.74458961 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74029099 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73347080 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72917726 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71373712 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70026175 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69150273 |
| 102 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68323869 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68245488 |
| 104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68083833 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67096249 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64509250 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.64116697 |
| 108 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63089999 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63010688 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62473359 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62313234 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61974919 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61922837 |
| 114 | Proteasome_Homo sapiens_hsa03050 | 0.60982172 |
| 115 | Phototransduction_Homo sapiens_hsa04744 | 0.60714968 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.59879778 |
| 117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59394402 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58844778 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55930697 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.55823651 |
| 121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55446291 |
| 122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54413017 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54155985 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.53100931 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52512855 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.51329066 |
| 127 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49289631 |
| 128 | Long-term depression_Homo sapiens_hsa04730 | 0.48360034 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47491770 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47325836 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.46502635 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44570035 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44492251 |
| 134 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44219363 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43777140 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42890067 |
| 137 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42601986 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41682941 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.39094912 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38930518 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37856379 |
| 142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37764906 |
| 143 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37606369 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36954797 |
| 145 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36715127 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36486712 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36255166 |
| 148 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36206578 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34678499 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.34444065 |
| 151 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32891402 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32101485 |
| 153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30901968 |
| 154 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30596531 |
| 155 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28435779 |
| 156 | Salmonella infection_Homo sapiens_hsa05132 | 0.27742150 |
| 157 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27575048 |
| 158 | Insulin resistance_Homo sapiens_hsa04931 | 0.27482443 |
| 159 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27206994 |
| 160 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22331865 |
| 161 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19743066 |

